These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12921222)

  • 1. Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.
    Remington G
    J Psychiatry Neurosci; 2003 Jul; 28(4):275-84. PubMed ID: 12921222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and typical antipsychotics.
    Ross DE
    Am J Psychiatry; 2004 Oct; 161(10):1925-6. PubMed ID: 15465996
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanisms of action of antipsychotic drugs: is atypicality superior in schizophrenia treatment?].
    Anil Yağcioğlu AE
    Turk Psikiyatri Derg; 2007; 18(4):364-74. PubMed ID: 18066727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is an atypical antipsychotic?
    Reynolds GP
    J Psychopharmacol; 1997; 11(3):195-9. PubMed ID: 9305410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
    Meltzer HY
    Biol Psychiatry; 1999 Jul; 46(1):144-9. PubMed ID: 10394487
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of dopamine and serotonin transmission in schizophrenia.
    Remington G
    Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
    Aringhieri S; Carli M; Kolachalam S; Verdesca V; Cini E; Rossi M; McCormick PJ; Corsini GU; Maggio R; Scarselli M
    Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits.
    Dean B; Scarr E
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):217-25. PubMed ID: 15180482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors.
    Seeman P
    CNS Neurosci Ther; 2011 Apr; 17(2):118-32. PubMed ID: 20560996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.